Abingdon Health (LON:ABDX) Posts Quarterly Earnings Results

Abingdon Health (LON:ABDX) issued its quarterly earnings data on Tuesday. The company reported GBX (0.43) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Stock Down 3.2%

ABDX stock opened at GBX 7.51 on Thursday. The firm’s 50-day moving average is GBX 6.63 and its two-hundred day moving average is GBX 6.48. The company has a market capitalization of £18.84 million, a price-to-earnings ratio of -8.07 and a beta of 0.25. Abingdon Health has a 52 week low of GBX 5.10 and a 52 week high of GBX 9. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.